About: http://webisa.webdatacommons.org/81676852

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Unlike aspirin and other older NSAIDs, celecoxib and rofecoxib do not inhibit platelet aggregation, so they are not appropriate as a substitute for aspirin for cardiovascular prophylaxis.
http://www.w3.org/ns/prov#wasQuotedFrom	nurseslearning.com